Neurocrine Biosciences, Inc. (NBIX)

NASDAQ: NBIX · Real-Time Price · USD

120.25

+1.47 (1.24%)

At close: May 15, 2025, 4:00 PM

120.27

+0.02 (0.02%)

After-hours: May 15, 2025, 4:44 PM EDT

Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of $11.90 billion as of May 15, 2025. Its market cap has decreased by -13.89% in one year.

Market Cap

11.90B

Enterprise Value

11.45B

1-Year Change

-13.89%

Ranking

#783

Market Cap Chart

Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $11.90B, an increase of 9,489.56%. That is a compound annual growth rate of 18.82%.

Market Cap History

Date	Market Cap	% Change
May 14, 2025	11.76B	-14.94%
Dec 31, 2024	13.82B	6.76%
Dec 29, 2023	12.95B	12.74%
Dec 30, 2022	11.48B	42.11%
Dec 31, 2021	8.08B	-9.78%
Dec 31, 2020	8.96B	-9.54%
Dec 31, 2019	9.90B	52.87%
Dec 31, 2018	6.48B	-5.69%
Dec 29, 2017	6.87B	104.24%
Dec 30, 2016	3.36B	-31.05%
Dec 31, 2015	4.88B	187.17%
Dec 31, 2014	1.70B	169.95%
Dec 31, 2013	629.00M	26.66%
Dec 31, 2012	496.60M	5.73%
Dec 30, 2011	469.70M	12.07%
Dec 31, 2010	419.10M	293.15%
Dec 31, 2009	106.60M	-13.68%
Dec 31, 2008	123.50M	-28.41%
Dec 31, 2007	172.50M	-56.31%
Dec 29, 2006	394.80M	-82.96%
Dec 30, 2005	2.32B	28.86%
Dec 31, 2004	1.80B	-6.54%
Dec 31, 2003	1.92B	37.67%
Dec 31, 2002	1.40B	3.88%
Dec 31, 2001	1.35B	84.02%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	658.30B
Johnson & Johnson	359.97B
AbbVie	320.92B
Novo Nordisk	289.00B
UnitedHealth Group	248.87B
Abbott Laboratories	232.01B
Novartis AG	211.47B
AstraZeneca	208.86B

Market Cap Rankings